Symptomatic patients have similar outcomes compared with asymptomatic patients after carotid artery stenting with emboli protection.
In a single-center cohort of 174 consecutive patients, we sought to evaluate whether the use of emboli protection devices (EPDs) results in equivalent rates of adverse events in symptomatic and asymptomatic patients after carotid artery stenting (CAS) with EPDs. Death or stroke occurred in 3.3% in the symptomatic group and in 3.5% of the asymptomatic group at 30 days (p = NS). At 6 months, there was also no significant difference in the rate of stroke or death between the groups. Unlike surgical revascularization, symptomatic patients did not have a greater risk for stroke and death compared with asymptomatic patients after CAS with EPDs.
Yen
Michael H
MH
Departm,ent of Cardiovascular Nedicine/F25, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
Lee
David S
DS
Kapadia
Samir
S
Sachar
Ravish
R
Bhatt
Deepak L
DL
Bajzer
Christopher T
CT
Yadav
Jay S
JS
D000368:Aged; D000369:Aged, 80 and over; D002340:Carotid Artery Diseases / Q000473:pathology / Q000601:surgery*; D015331:Cohort Studies; D005260:Female; D005374:Filtration / Q000295:instrumentation*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009820:Ohio / Q000453:epidemiology; D011446:Prospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D015607:Stents; D020521:Stroke / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control; D016019:Survival Analysis; D016896:Treatment Outcome